Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 43 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Inactivating mutations in NPC1L1 and protection from coronary heart diseaseStitziel, N.O.; Won, H.H.; Morrison, A.C.; Peloso, G.M.; Do, R.; Lange, L.A.; Fontanillas, P.; Gupta, N.; Duga, S.; Goel, A.; Farrall, M.; Saleheen, D.; Ferrario, P.; König, I.; Asselta, R.; Merlini, P.A.; Marziliano, N.; Notarangelo, M.F.; Schick, U.; Auer, P.; et al.
2017Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association studyZewinger, S.; Kleber, M.E.; Tragante, V.; McCubrey, R.O.; Schmidt, A.F.; Direk, K.; Laufs, U.; Werner, C.; Koenig, W.; Rothenbacher, D.; Mons, U.; Breitling, L.P.; Brenner, H.; Jennings, R.T.; Petrakis, I.; Triem, S.; Klug, M.; Filips, A.; Blankenberg, S.; Waldeyer, C.; et al.
2013A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasCortes, J.E.; Kim, D.W.; Pinilla-Ibarz, J.; Le Coutre, P.; Paquette, R.; Chuah, C.; Nicolini, F.E.; Apperley, J.F.; Khoury, H.J.; Talpaz, M.; DiPersio, J.; DeAngelo, D.J.; Abruzzese, E.; Rea, D.; Baccarani, M.; Müller, M.C.; Gambacorti-Passerini, C.; Wong, S.; Lustgarten, S.; Rivera, V.M.; et al.
2013The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphismKlebe, S.; Golmard, J.-L.; Nalls, M.A.; Saad, M.; Singleton, A.B.; Bras, J.M.; Hardy, J.; Simon-Sanchez, J.; Heutink, P.; Kuhlenbaeumer, G.; Charfi, R.; Klein, C.; Hagenah, J.; Gasser, T.; Wurster, I.; Lesage, S.; Lorenz, D.; Deuschl, G.; Durif, F.; Pollak, P.; et al.
2014Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucomaGharahkhani, P.; Burdon, K.; Fogarty, R.; Sharma, S.; Hewitt, A.; Martin, S.; Law, M.; Cremin, K.; Bailey, J.; Loomis, S.; Pasquale, L.; Haines, J.; Hauser, M.; Viswanathan, A.; McGuffin, P.; Topouzis, F.; Foster, P.; Graham, S.; Casson, R.; Chehade, M.; et al.
2014LgG4 immunostaining and its implications in orbital inflammatory diseaseWong, A.; Planck, S.; Choi, D.; Harrington, C.; Troxell, M.; Houghton, D.; Stauffer, P.; Wilson, D.; Grossniklaus, H.; Dailey, R.; Ng, J.; Steele, E.; Harris, G.; Czyz, C.; Foster, J.; White, V.; Dolman, P.; Kazim, M.; Patel, P.; Edward, D.; et al.; Wallace, G.
2015Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisDe Cruz, P.; Kamm, M.A.; Hamilton, A.L.; Ritchie, K.J.; Krejany, E.O.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.C.; Andrews, J.M.; Bampton, P.A.; Jakobovits, S.; Florin, T.H.; Gibson, P.R.; Debinski, H.; Gearry, R.B.; Macrae, F.A.; Leong, R.W.; Kronborg, I.; Radford-Smith, G.; et al.
2015Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non–small-cell lung cancerRamalingam, S.S.; Shtivelband, M.; Soo, R.A.; Barrios, C.H.; Makhson, A.; Segalla, J.G.; Pittman, K.B.; Kolman, P.; Pereira, J.R.; Srkalovic, G.; Belani, C.P.; Axelrod, R.; Owonikoko, T.K.; Qin, Q.; Qian, J.; McKeegan, E.M.; Devanarayan, V.; McKee, M.D.; Ricker, J.L.; Carlson, D.M.; et al.
2016Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic targetAsim, M.; Massie, C.; Orafidiya, F.; Pértega-Gomes, N.; Warren, A.; Esmaeili, M.; Selth, L.; Zecchini, H.; Luko, K.; Qureshi, A.; Baridi, A.; Menon, S.; Madhu, B.; Escriu, C.; Lyons, S.; Vowler, S.; Zecchini, V.; Shaw, G.; Hessenkemper, W.; Russell, R.; et al.
2016Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignanciesLewinsohn, M.; Brown, A.L.; Weinel, L.M.; Phung, C.; Rafidi, G.; Lee, M.K.; Schreiber, A.W.; Feng, J.; Babic, M.; Chong, C.E.; Lee, Y.; Yong, A.; Suthers, G.K.; Poplawski, N.; Altree, M.; Phillips, K.; Jaensch, L.; Fine, M.; D'Andrea, R.J.; Lewis, I.D.; et al.